ConductScience.org, home

Paper8201224

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.

Stiehl A and 5 others. J Hepatol, 1994. Cited by 186 papers, by iCite.

Cite this record

ConductScience Library. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. Papers, record 8201224. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8201224

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.
PubMed
Journal
J Hepatol
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
186
iCite
Relative citation ratio, by iCite
6.5
iCite
Revised in PubMed
2022-11-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stiehl AA
2Walker SS
3Stiehl LL
4Rudolph GG
5Hofmann WJW J
6Theilmann LL

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholangitis, SclerosingMajor topic
Ursodeoxycholic AcidMajor topic
Adult
Bile Acids and Salts
Cholangiopancreatography, Endoscopic Retrograde
Clinical Enzyme Tests
Colitis, Ulcerative
Double-Blind Method
Humans
Liver
Liver Function Tests
Pilot Projects
Time Factors

Source PubMed

Download CSV of topics

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.

PMIDTitleJournalYearIn PapersSource
38862968Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis.BMC Med Genomics2024https://conductscience.org/library/papers/38862968PubMed
37007752Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.Prz Gastroenterol2023https://conductscience.org/library/papers/37007752PubMed
35990218Review of pharmacotherapeutic treatments for primary sclerosing cholangitis.Can Liver J2019https://conductscience.org/library/papers/35990218PubMed
35359068[Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)].Zhonghua Gan Zang Bing Za Zhi2022https://conductscience.org/library/papers/35359068PubMed
31762074
Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
Aliment Pharmacol Ther2020https://conductscience.org/library/papers/31762074PubMed
31154395British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.Gut2019https://conductscience.org/library/papers/31154395PubMed
29951926Clinical guidelines for primary sclerosing cholangitis 2017.J Gastroenterol2018https://conductscience.org/library/papers/29951926PubMed
29138587Primary sclerosing cholangitis: diagnostic and management challenges.Clin Exp Gastroenterol2017https://conductscience.org/library/papers/29138587PubMed
28417463Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28417463PubMed
28381955Management Of Primary Sclerosing Cholangitis.Gastroenterol Hepatol (N Y)2006https://conductscience.org/library/papers/28381955PubMed
26770670A review of the medical treatment of primary sclerosing cholangitis in the 21st century.Ther Adv Chronic Dis2016https://conductscience.org/library/papers/26770670PubMed
26378046A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.Oncotarget2015https://conductscience.org/library/papers/26378046PubMed
25434314Overlap syndromes: an emerging diagnostic and therapeutic challenge.Saudi J Gastroenterol2014https://conductscience.org/library/papers/25434314PubMed
24529302Primary sclerosing cholangitis: diagnosis and treatment.Dtsch Arztebl Int2013https://conductscience.org/library/papers/24529302PubMed
23634279Treatment of autoimmune liver disease: current and future therapeutic options.Ther Adv Chronic Dis2013https://conductscience.org/library/papers/23634279PubMed
22228965Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.World J Gastroenterol2012https://conductscience.org/library/papers/22228965PubMed
21656181In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment.Dig Dis Sci2011https://conductscience.org/library/papers/21656181PubMed
21249655Bile acids for primary sclerosing cholangitis.Cochrane Database Syst Rev2011https://conductscience.org/library/papers/21249655PubMed
21180531Current status of therapy in autoimmune liver disease.Ther Adv Gastroenterol2009https://conductscience.org/library/papers/21180531PubMed
20127368Bezafibrate for the treatment of primary sclerosing cholangitis.J Gastroenterol2010https://conductscience.org/library/papers/20127368PubMed

See all 48 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GGT12678PubTator's text mininghttps://conductscience.org/library/genes/2678

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8201224

GET https://conductscience.org/api/papers/v1/8201224/cited_by?page=2